Overview of the Side-Effects of FDA- and/or EMA-Approved Targeted Therapies for the Treatment of Hematological Malignancies

In the last decade there has been tremendous effort in offering better therapeutic management strategies to patients with hematologic malignancies. These efforts have ranged from biological to clinical approaches and resulted in the rapid development of new approaches. The main “problem” that comes...

Descripción completa

Detalles Bibliográficos
Autores principales: Constantinescu, Catalin, Pasca, Sergiu, Zimta, Alina-Andreea, Tat, Tiberiu, Rus, Ioana, Teodorescu, Patric, Iluta, Sabina, Tanase, Alina, Colita, Anca, Sigurjonsson, Olafur, Einsele, Hermann, Tomuleasa, Ciprian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565707/
https://www.ncbi.nlm.nih.gov/pubmed/32911829
http://dx.doi.org/10.3390/jcm9092903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565707/
https://www.ncbi.nlm.nih.gov/pubmed/32911829
http://dx.doi.org/10.3390/jcm9092903

Ejemplares similares